MarkWide Research

Sale!

Remote Patient Monitoring Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: August, 2022
No of Pages: 169
Delivery Format: PDF + Excel

$2,950.00

Report Description

The remote monitoring of patients market is predicted to grow to USD 117.1 billion in 2025, up from USD 23.2 billion by 2020, with an annual rate of 38.2 percent between 2020 to 2025. Growing geriatric populations and the need to expand healthcare accessibility, the financial benefits of remote health and telehealth monitoring, the advantages of RPM to lessen the demand for medical expenses, advances in telecommunications technology, increasing prevalence of chronic diseases, and the increasing investment in RPM and Telehealth are among the main factors driving the expansion of this market. However, the variations in regulatory requirements between regions, the risk of healthcare fraud, and the informal utilization of social media practices are expected to limit the growth of the market over the forecast time… Remote monitoring of patients (RPM) is a method utilized to collect health and medical information from people at one place and electronically transfer it to a healthcare provider in another location. RPM can be used to monitor and analyze physiological parameters like blood oxygen levels and vital indicators, blood pressure, heart rate, and blood sugar levels, which improves the standard of healthcare and the living quality and can help to predict early the onset of problems and exacerbations. This decreases the frequency of emergency department visits and the time spent in hospitalization. This is due to the enormous undiagnosed patient population, which improves access to healthcare services, and the high likelihood of developing chronic diseases due to rapid urbanization. Furthermore, the rise in chronic illnesses like diabetes and COPD is the main reason behind the dramatic increase.

Diabetes, chronic heart disease, and chronic respiratory illnesses are the most significant cause of global morbidity and mortality. Chronic care management is responsible for 75% of medical expenses. The rising prevalence of chronic illnesses creates a massive financial burden on caregivers. This is where RPM techniques come in to detect tiny changes in patients’ biochemical data and encourage self-monitoring. It also reduces admissions to the hospital and avoids unnecessary hospitalizations. Additionally, these technologies reduce the number of visits to the doctor’s office and decrease the travel expenses essential to get high-quality medical treatment. From a short- and long-term perspective, properly implemented RPM technologies can expand access to high-quality healthcare and save time and cash.

REMOTE PATIENT MONITORING MARKET dynamics

Driver: growing Geriatric population, and the need for expanded access to healthcare

The increasing population of this segment will increase the demand for long-term care and add to the burden on government and health systems. This is a good thing for consumers who want remote monitoring. Remote patient monitoring could increase the accessibility of and access to healthcare, decreasing unnecessary hospital visits, admissions and readmissions, and the cost and time required to travel to meet medical professionals.

Restraint: Healthcare Fraud

Healthcare fraud is a crucial issue in Telehealth and telemedicine practices. There are many ways patients or physicians are swindled; for example, doctors’ names and accounts can be used to obtain payments from insurance companies as well as non-eligible or unlisted institutions can use improper billing and coding for fraudulent claims.

Challenge challenges: health care affordability, behavioral barriers, and the absence of knowledge

These barriers might not be the primary limitation, but they still create significant obstacles to Telehealth and the adoption of telemedicine. Patients and physicians are often inexperienced with new procedures and don’t immediately abandon traditional (conventional) methods. Some older people are hesitant to utilize Telehealth or remote medicine due to their inexperience with modern technology.

Potential: the high value of RPM in fighting infectious diseases and epidemics

Infectious illnesses are among the most difficult to treat in hospitals because healthcare workers and patients are equally susceptible to contracting the disease. In such cases, telemedicine has excellent potential to limit the spread of epidemics and healthcare-associated infections owing to its inherent benefits, such as the early detection of diseases and virtual visits, consequently reducing overall patient exposure. It reduces the overall number of in-person visits and the travel involved in the treatment process. It’s a better delivery method of care and slows the spreading of infectious diseases.

Providers held the most significant market share 

Based on the number of end-users, the remote monitoring market is broadly classified into payers, providers, patients, and other users. The segment for providers represented the most significant portion of the market worldwide in 2019. This is due to the increasing use of remote monitoring for older and chronically ill patients, the advancements with RPM Monitoring devices, and the growing number of RPM services provided by providers.

North America accounted for most of the remote monitoring market 

In 2019, North America accounted for the most significant share of the remote monitoring market and was followed by Europe. The substantial portion of North America in the RPM market is attributed to the increasing incidence of chronic diseases, the need to cut medical expenses, and the rising geriatric population.

The report focuses on the study of remote patient monitoring according to the conditions, components, and geographic location. Based on the type of condition, the market is classified as congestive cardiac failure (CHF) and chronic obstructive lung disease (COPD), psychological health, blood pressure, and others. Based on the components, the market is split into software and devices. Based on geographic location, the remote monitoring market is examined about four central regions:

  • North America (U.S., Canada as well as Mexico).
  • Europe (Germany, France, U.K., Italy, Spain, and Russia).
  • Asia-Pacific (Japan, China, India, Australia, South Korea, and Taiwan) and LAMEA (Brazil, Turkey, Venezuela, Saudi Arabia, and the Republic of South Africa).

The report lists the revenues that are generated by the selling of these categories.

The leading players featured in this report are Aerotel Medical Systems (1988) Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, General Electric Company, Draeger, Nihon Kohden Corporation, Medtronic Plc, Masimo Corporation, BTG plc, Abbott Laboratories, Johnson and Johnson and Omron Corporation. Other companies in the remote patient monitoring market are A&D Company, Spacelabs Healthcare, Smiths Medical, Aipermon GmbH & Co. KG, Roche, Jawbone, Docobo Ltd., Microlife Corporation, Schiller AG, SHL Telemedicine, and Sorin Group.

The market will gain momentum in the emerging Asia-Pacific, Africa, and Latin America. The huge undiagnosed patient population and rapid urbanization, the rise in disposable income, increased healthcare funding from the government, and a rise in awareness of RPM technologies are some of the significant elements that drive the constant market expansion across these areas. But, there are urgent concerns regarding the price of technologies, particularly in third-world countries and developing nations, like India and China.

The Russian market for remote patient monitoring is expected to expand at a rate of 19.3 percent over the forecast time. The main reasons, like a lack of awareness and concerns regarding price limitations, hinder the development of remote monitoring in the region. But, the existence of untapped markets could increase the market size. In addition, the increasing concentration of RPM companies in new markets (such as APAC and LAMEA countries) is expected to aid in expanding the remote monitoring market.

Key Benefits For Stakeholders

  • The report offers a comprehensive review of the present market trends, estimates, and the dynamics of the remote monitoring market between 2014 and 2022 to pinpoint the most promising opportunities.
  • The Porter Five Forces analysis reveals the potential of buyers and suppliers to help stakeholders make profitable business decisions and increase their supplier-buyer network.
  • Profound analysis and the market for remote monitoring size and segmentation aid in discerning the most popular market opportunities.
  • Each region’s most important countries are identified according to their contributions to the market.
  • The segment of market player positioning helps to benchmark and gives a complete understanding of the current situation of companies in the remote monitoring of the patients market.
Remote Patient Monitoring Market Report Scope and Segmentation 
 
ATTRIBUTESDETAILS
ESTIMATED YEAR2022
BASE YEAR2021
FORECAST YEAR2030
HISTORICAL YEAR2017-2021
UNITValue (USD Million/Billion)
BY REGIONNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

Key Market Segments

The market for remote monitoring of patients via the

  • Services & Software
  • Devices
    • Cardiac Monitoring Devices
    • Neurological Monitoring Devices
    • Respiratory Monitoring Devices
    • Multiparameter Monitoring Devices
    • Blood Glucose Monitoring Devices
    • Fetal & Neonatal Monitoring Devices
    • Weight Monitoring Devices
    • Other Monitoring Devices

Market monitoring for Remote Patients for End Users

  • Providers
    • Hospitals and Clinics
    • Home Care Settings and Long Term Care Centers
    • Ambulatory Care Centers
    • Other End Users
  • Payers
  • Patients
  • Other End Users

Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy
    • France
    • UK
    • Spain
    • Poland
    • Russia
    • The Netherlands
    • Norway
    • Czech Republic
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Malaysia
    • Thailand
    • Singapore
    • Australia & New Zealand
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Northern Africa
    • Rest of MEA

List Of Key Companies

  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • General Electric Company
  • Nihon Kohden Corporation
  • Medtronic Plc
  • Masimo Corporation
  • Abbott Laboratories
  • Johnson and Johnson
  • Omron Corporation
  • BTG plc
  • Draeger
  • Nihon Kohden America
  • Roche
  • Smiths Medical
  • Spacelabs Healthcare

Table of Contents

CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Government regulations

3.3.1 U.S. FDA
3.3.2 Europe CE Mark
3.3.3 Ministry of Health, Labor and Welfare (MHLW)

3.4 Reimbursement scenarios
3.5 Clinical trials
3.6 Patent analysis
3.7 Porters Five Forces analysis
3.8 Market dynamics

3.8.1 Drivers

3.8.1.1 Rising incidence of chronic diseases
3.8.1.2 Technological advancements
3.8.1.3 Increase in out of pocket expenses

3.8.2 Restraints

3.8.2.1 Unstable reimbursement regulations
3.8.2.2 Limited awarenesS

3.8.3 Market Opportunities

3.8.3.1 Lucrative opportunities in emerging markets
3.8.3.2 Undifferntiated products

CHAPTER 4 WORLD REMOTE PATIENT MONITORING MARKET, BY CONDITION

4.1 Overview

4.1.1 Market size and forecast

4.2 Congestive heart failure (CHF)

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 Diabetes

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 Chronic obstructive pulmonary disease (COPD)

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

4.5 Blood pressure monitoring

4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast

4.6 Mental health

4.6.1 Key market trends
4.6.2 Key growth factors and opportunities
4.6.3 Market size and forecast

4.7 Others

4.7.1 Key market trends
4.7.2 Key growth factors and opportunities
4.7.3 Market size and forecast

CHAPTER 5 WORLD REMOTE PATIENT MONITORING MARKET, BY COMPONENTS

5.1 Overview

5.1.1 Market size and forecast

5.2 Devices

5.2.1 Market size and forecast

5.3 Software

5.3.1 Market size and forecast

CHAPTER 6 WORLD REMOTE PATIENT MONITORING MARKET, BY GEOGRAPHY

6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 Market size and forecast
6.2.5 U.S.
6.2.6 Canada
6.2.7 Mexico

6.3 Europe

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Market size and forecast
6.3.5 Germany
6.3.6 France
6.3.7 U.K.
6.3.8 Italy
6.3.9 Spain
6.3.10 Russia
6.3.11 Rest of Europe

6.4 Asia Pacific

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Market size and forecast
6.4.5 Japan
6.4.6 China
6.4.7 Australia
6.4.8 India
6.4.9 South Korea
6.4.10 Taiwan
6.4.11 Rest of Asia-Pacific

6.5 LAMEA

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Market size and forecast
6.5.5 Brazil
6.5.6 Turkey
6.5.7 Venezuela
6.5.8 Saudi Arabia
6.5.9 Republic of South Africa
6.5.10 Rest of LAMEA

CHAPTER 7 COMPANY PROFILES

7.1 Aerotel Medical Systems (1988) Ltd.

7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
1.1.4 Key strategic moves & developments

7.2 Biotronik SE & Co. KG

7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Key strategic moves & developments

7.3 Boston Scientific Corporation

7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Business performance
7.3.5 Key strategic moves & developments

7.4 General Electric Company

7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Operating business segments
7.4.4 Business performance
7.4.5 Key strategic moves & developments

7.5 Nihon Kohden Corporation

7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Operating business segments
7.5.4 Business performance
7.5.5 Key strategic moves & developments

7.6 Medtronic Plc

7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Business performance
7.6.5 Key strategic moves & developments

7.7 Masimo Corporation

7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Business performance
7.7.5 Key strategic moves & developments

7.8 Abbott Laboratories

7.8.1 Company Overview
7.8.2 Company Snapshot
7.8.3 Operating business segments
7.8.4 Business performance
7.8.5 Key strategic moves & developments

7.9 Johnson and Johnson

7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments
7.9.4 Business performance
7.9.5 Key strategic moves & developments

7.10 Omron Corporation

7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Operating business segments
7.10.4 Business performance
7.10.5 Key strategic moves & developments

Other players in the RPM market include (profiles not included in the report)

  • A&D Company, Limited
  • Aipermon GmbH & Co. KG
  • Jawbone
  • Docobo Ltd.
  • Microlife Corporation
  • Schiller AG
  • SHL Telemedicine
  • Sorin Group
  • BTG plc
  • Draeger
  • Nihon Kohden America
  • Roche
  • Smiths Medical
  • Spacelabs Healthcare

List of Figures

FIG. 1 TOP INVESTMENT POCKETS: WORLD REMOTE PATIENT MONITORING, BY CONDITION
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (20132016)
FIG. 3 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 1 PATENTS REGISTERED/APPROVED WORLDWIDE, 20102016
FIG. 2 PATENTS REGISTERED/APPROVED YEAR-WISE
FIG. 3 PATENTS REGISTERED/APPROVED, BY COMPANY (2010-2016)
FIG. 4 TOP IMPACTING FACTORS
FIG. 5 U.S. REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 6 CANADA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 7 MEXICO REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 8 GERMANY REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 9 FRANCE REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 10 U.K. REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 11 ITALY REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 12 SPAIN REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 13 RUSSIA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 14 REST OF EUROPE REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 15 JAPAN REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 16 CHINA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 17 AUSTRALIA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 18 INDIA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 19 SOUTH KOREA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 20 TAIWAN REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 21 REST OF ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 22 BRAZIL REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 23 TURKEY REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 24 VENEZUELA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 25 SAUDI ARABIA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 26 REPUBLIC OF SOUTH AFRICA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 27 REST OF LAMEA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 28 BOSTON: REVENUE BY YEAR ($MILLION)
FIG. 29 BOSTON: REVENUE BY SEGMENT, 2015 (%)
FIG. 30 BOSTON: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 31 GE: REVENUE BY YEAR ($MILLION)
FIG. 32 GE: REVENUE BY SEGMENT, 2015 (%)
FIG. 33 GE: HEALTHCARE REVENUE BY SUB SEGMENT, 2015 (%)
FIG. 34 GE: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 35 NIHON KOHDEN: REVENUE BY YEAR ($MILLION)
FIG. 36 NIHON KOHDEN: REVENUE BY SEGMENT, 2015 (%)
FIG. 37 NIHON KOHDEN: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 38 MEDTRONIC: REVENUE BY YEAR ($MILLION)
FIG. 39 MEDTRONIC: REVENUE BY SEGMENT, 2015 (%)
FIG. 40 MEDTRONIC: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 41 MASIMO: REVENUE BY YEAR ($MILLION)
FIG. 42 MASIMO: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 43 ABBOTT: REVENUE BY YEAR ($MILLION)
FIG. 44 ABBOTT: REVENUE BY SEGMENT, 2015 (%)
FIG. 45 ABBOTT: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 46 JOHNSON & JOHNSON: REVENUE BY YEAR ($MILLION)
FIG. 47 JOHNSON & JOHNSON: REVENUE BY SEGMENT, 2015 (%)
FIG. 48 JOHNSON & JOHNSON: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 49 OMRON: REVENUE BY YEAR ($MILLION)
FIG. 50 OMRON: REVENUE BY SEGMENT, 2015 (%)
FIG. 51 OMRON: REVENUE BY GEOGRAPHY, 2015 (%)

List of Tables

TABLE 1 CLINICAL TRIALS, REMOTE PATIENT MONITORING MARKET, 20142016
TABLE 1 PATENTS REGISTERED/APPROVED, BY COUNTRY (20102016)
TABLE 2 PATENTS REGISTERED/APPROVED WORLDWIDE, 20102016
TABLE 3 PATENTS REGISTERED/APPROVED, BY YEAR (20102016)
TABLE 4 PATENTS REGISTERED/APPROVED, BY COMPANY (20102016)
TABLE 1 WORLD REMOTE PATIENT MONITORING MARKET, BY CONDITION, 20142022 ($MILLION)
TABLE 2 CHF REMOTE PATIENT MONITORING MARKET, BY REGION, 20142022 ($MILLION)
TABLE 3 CHF REMOTE PATIENT MONITORING MARKET, BY REGION, 20142022 ($MILLION)
TABLE 4 COPD REMOTE PATIENT MONITORING MARKET, BY REGION, 20142022 ($MILLION)
TABLE 5 BLOOD PATIENT MONITORING REMOTE PATIENT MONITORING MARKET, BY REGION, 20142022 ($MILLION)
TABLE 6 MENTAL HELATH REMOTE PATIENT MONITORING MARKET, BY REGION, 20142022 ($MILLION)
TABLE 7 REMOTE PATIENT MONITORING MARKET OF OTHER CONDITIONS, BY REGION, 20142022 ($MILLION)
TABLE 8 WORLD REMOTE PATIENT MONITORING MARKET, BY COMPONENTS, 20142022 ($MILLION)
TABLE 9 REMOTE PATIENT MONITORING MARKET FOR DEVICE COMPONENTS, BY REGION, 20142022 ($MILLION)
TABLE 10 REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY REGION, 20142022 ($MILLION)
TABLE 11 WORLD REMOTE PATIENT MONITORING MARKET, BY REGION, 20142022 ($MILLION)
TABLE 12 NORTH AMERICA REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 13 NORTH AMERICA REMOTE PATIENT MONITORING MARKET, BY COMPONENTS, 20142022 ($MILLION)
TABLE 14 EUROPE REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 15 EUROPE REMOTE PATIENT MONITORING MARKET, BY COMPONENTS, 20142022 ($MILLION)
TABLE 16 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 17 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET, BY COMPONENTS, 20142022 ($MILLION)
TABLE 18 LAMEA REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 19 LAMEA REMOTE PATIENT MONITORING MARKET, BY COMPONENTS, 20142022 ($MILLION)
TABLE 20 AEROTEL: COMPANY SNAPSHOT
TABLE 21 AEROTEL: OPERATING SEGMENTS
TABLE 22 BIOTRONIK: COMPANY SNAPSHOT
TABLE 23 BIOTRONIK: OPERATING SEGMENTS
TABLE 24 BOSTON: COMPANY SNAPSHOT
TABLE 25 BOSTON: OPERATING SEGMENTS
TABLE 26 GE: COMPANY SNAPSHOT
TABLE 27 GE: OPERATING SEGMENTS
TABLE 28 NIHON KOHDEN: COMPANY SNAPSHOT
TABLE 29 NIHON KOHDEN: PRODUCTS
TABLE 30 MEDTRONIC: COMPANY SNAPSHOT
TABLE 31 MEDTRONIC: OPERATING SEGMENTS
TABLE 32 MASIMO:COMPANY SNAPSHOT
TABLE 33 MASIMO: OPERATING SEGMENTS
TABLE 34 ABBOTT: COMPANY SNAPSHOT
TABLE 35 ABBOTT: PRODUCTS
TABLE 36 JOHNSON & JOHNSON :COMPANY SNAPSHOT
TABLE 37 JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 38 OMRON: COMPANY SNAPSHOT
TABLE 39 OMRON: OPERATING SEGMENTS

Major Companies

  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • General Electric Company
  • Nihon Kohden Corporation
  • Medtronic Plc
  • Masimo Corporation
  • Abbott Laboratories
  • Johnson and Johnson
  • Omron Corporation
  • BTG plc
  • Draeger
  • Nihon Kohden America
  • Roche
  • Smiths Medical
  • Spacelabs Healthcare

 

Major Segmentation

The market for remote monitoring of patients via the

  • Services & Software
  • Devices
    • Cardiac Monitoring Devices
    • Neurological Monitoring Devices
    • Respiratory Monitoring Devices
    • Multiparameter Monitoring Devices
    • Blood Glucose Monitoring Devices
    • Fetal & Neonatal Monitoring Devices
    • Weight Monitoring Devices
    • Other Monitoring Devices

Market monitoring for Remote Patients for End Users

  • Providers
    • Hospitals and Clinics
    • Home Care Settings and Long Term Care Centers
    • Ambulatory Care Centers
    • Other End Users
  • Payers
  • Patients
  • Other End Users

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF